• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部副神经节瘤不断变化的模式:每位耳鼻喉科医生都需要了解的内容。

The Changing Paradigm of Head and Neck Paragangliomas: What Every Otolaryngologist Needs to Know.

作者信息

Cass Nathan D, Schopper Melissa A, Lubin Jonathan A, Fishbein Lauren, Gubbels Samuel P

机构信息

Department of Otolaryngology, University of Colorado School of Medicine, Aurora, CO, USA.

Department of Surgery, Maine Medical Center, Portland, ME, USA.

出版信息

Ann Otol Rhinol Laryngol. 2020 Nov;129(11):1135-1143. doi: 10.1177/0003489420931540. Epub 2020 Jun 2.

DOI:10.1177/0003489420931540
PMID:32486832
Abstract

BACKGROUND

Recommendations regarding head and neck paragangliomas (HNPGL) have undergone a fundamental reorientation in the last decade as a result of increased understanding of the genetic and pathophysiologic basis of these disorders.

OBJECTIVE

We aim to provide an overview of HNPGL and recent discoveries regarding their molecular genetics, along with updated recommendations on workup, treatment, and surveillance, and their implications for otolaryngologists treating patients with these disorders.

RESULTS

susceptibility gene mutations, encoding subunits of the enzyme succinate dehydrogenase (SDH), give rise to the Hereditary Pheochromocytoma/Paraganglioma Syndromes. , and mutations each result in unique phenotypes with distinct penetrance and risk for variable tumor development as well as metastasis. Genetic and biochemical testing is recommended for every patient with HNPGL. Multifocal disease should be managed in multi-disciplinary fashion. Patients with mutations require frequent biochemical screening and whole-body imaging, as well as lifelong follow-up with an expert in hereditary pheochromocytoma and paraganglioma syndromes.

CONCLUSION

Otolaryngologists are likely to encounter patients with HNPGL. Keeping abreast of the latest recommendations, especially regarding genetic testing, workup for additional tumors, multi-disciplinary approach to care, and need for lifelong surveillance, will help otolaryngologists appropriately care for these patients.

摘要

背景

由于对这些疾病的遗传和病理生理基础有了更多了解,过去十年中关于头颈部副神经节瘤(HNPGL)的建议发生了根本性的重新定位。

目的

我们旨在概述HNPGL及其分子遗传学的最新发现,同时提供关于检查、治疗和监测的最新建议,以及它们对治疗这些疾病患者的耳鼻喉科医生的影响。

结果

编码琥珀酸脱氢酶(SDH)亚基的易感基因突变会引发遗传性嗜铬细胞瘤/副神经节瘤综合征。 、 和 突变各自导致具有独特外显率以及不同肿瘤发生和转移风险的独特表型。建议对每位HNPGL患者进行基因和生化检测。多灶性疾病应以多学科方式进行管理。携带 突变的患者需要频繁进行生化筛查和全身成像,以及由遗传性嗜铬细胞瘤和副神经节瘤综合征专家进行终身随访。

结论

耳鼻喉科医生很可能会遇到HNPGL患者。紧跟最新建议,特别是关于基因检测、其他肿瘤的检查、多学科护理方法以及终身监测的必要性,将有助于耳鼻喉科医生妥善护理这些患者。

相似文献

1
The Changing Paradigm of Head and Neck Paragangliomas: What Every Otolaryngologist Needs to Know.头颈部副神经节瘤不断变化的模式:每位耳鼻喉科医生都需要了解的内容。
Ann Otol Rhinol Laryngol. 2020 Nov;129(11):1135-1143. doi: 10.1177/0003489420931540. Epub 2020 Jun 2.
2
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.副神经节瘤和嗜铬细胞瘤易感性中线粒体复合物II亚基SDHD、SDHB和SDHC的遗传分析。
Clin Endocrinol (Oxf). 2003 Dec;59(6):728-33. doi: 10.1046/j.1365-2265.2003.01914.x.
3
Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.变异类型与 SDHB、SDHC 和 SDHD 相关的嗜铬细胞瘤-副神经节瘤的疾病特征有关。
J Med Genet. 2020 Feb;57(2):96-103. doi: 10.1136/jmedgenet-2019-106214. Epub 2019 Sep 6.
4
Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.与SDHC基因突变相关的副神经节瘤综合征的预测因素及患病率
JAMA. 2005 Oct 26;294(16):2057-63. doi: 10.1001/jama.294.16.2057.
5
Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients.SDHD 基因突变是荷兰头颈部副神经节瘤患者临床特征的主要决定因素。
Clin Endocrinol (Oxf). 2011 Nov;75(5):650-5. doi: 10.1111/j.1365-2265.2011.04097.x.
6
Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update.比利时患者嗜铬细胞瘤和副神经节瘤中 SDHx 突变的流行率和谱:更新。
Horm Metab Res. 2012 May;44(5):349-53. doi: 10.1055/s-0032-1311610. Epub 2012 May 7.
7
Clinical aspects of SDHx-related pheochromocytoma and paraganglioma.与SDHx相关的嗜铬细胞瘤和副神经节瘤的临床特征
Endocr Relat Cancer. 2009 Jun;16(2):391-400. doi: 10.1677/ERC-08-0284. Epub 2009 Feb 3.
8
High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.比利时头颈部副神经节瘤中SDHB突变的高患病率。
J Hypertens. 2008 Jul;26(7):1395-401. doi: 10.1097/HJH.0b013e3282ffdc54.
9
Genetics of hereditary head and neck paragangliomas.遗传性头颈部副神经节瘤的遗传学
Head Neck. 2014 Jun;36(6):907-16. doi: 10.1002/hed.23436. Epub 2013 Nov 30.
10
Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.与SDHB和SDHD基因突变相关的副神经节瘤综合征的独特临床特征。
JAMA. 2004 Aug 25;292(8):943-51. doi: 10.1001/jama.292.8.943.

引用本文的文献

1
Management of Head and Neck Paragangliomas: AGREE II Appraisal of Clinical Practice Guidelines.头颈部副神经节瘤的管理:临床实践指南的AGREE II评估
Ann Surg Oncol. 2025 Jun 28. doi: 10.1245/s10434-025-17682-2.
2
Optimal Screening for Hereditary Head and Neck Paraganglioma in Asymptomatic SDHx Variant Carriers in the Netherlands.荷兰无症状SDHx变异携带者遗传性头颈部副神经节瘤的最佳筛查
J Neurol Surg B Skull Base. 2024 Mar 1;86(1):1-5. doi: 10.1055/s-0044-1781438. eCollection 2025 Feb.
3
Clinical Characteristics and Outcomes of Tympanomastoid Paragangliomas: A Report from Slovenia.
鼓室乳突副神经节瘤的临床特征与预后:来自斯洛文尼亚的报告
Cancers (Basel). 2024 Sep 17;16(18):3178. doi: 10.3390/cancers16183178.
4
Management and follow-up strategies for patients with head and neck paraganglioma.头颈部副神经节瘤患者的管理和随访策略。
Eur J Endocrinol. 2024 Sep 30;191(4):389-398. doi: 10.1093/ejendo/lvae113.
5
Pediatric carotid body tumors: A case report and systematic review.小儿颈动脉体瘤:一例报告及系统评价
J Vasc Surg Cases Innov Tech. 2024 Jul 22;10(6):101584. doi: 10.1016/j.jvscit.2024.101584. eCollection 2024 Dec.
6
Tumor volume changes after stereotactic, hypofractionated and conventional radiotherapy in paragangliomas of head and neck.头颈部副神经节瘤立体定向、低分割和常规放疗后的肿瘤体积变化。
Cancer Med. 2024 Sep;13(17):e70232. doi: 10.1002/cam4.70232.
7
[New progress in the diagnosis and treatment of jugular paragangliomas].[颈静脉球瘤诊断与治疗的新进展]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Sep;38(9):830-833. doi: 10.13201/j.issn.2096-7993.2024.09.010.
8
Head and Neck Paraganglioma (HNPGL) Registry: A study protocol for prospective data collection in patients with Head and Neck Paragangliomas.头颈部副神经节瘤(HNPGL)登记处:头颈部副神经节瘤患者前瞻性数据收集研究方案。
PLoS One. 2024 Jul 25;19(7):e0307311. doi: 10.1371/journal.pone.0307311. eCollection 2024.
9
Otology-Neurotology 2020 US Workforce Distribution.2020年美国耳科学-神经耳科学劳动力分布
Otol Neurotol Open. 2021 Dec 9;1(2):e007. doi: 10.1097/ONO.0000000000000007. eCollection 2021 Dec.
10
Hypoxic Signaling Pathways in Carotid Body Tumors.颈动脉体瘤中的缺氧信号通路
Cancers (Basel). 2024 Jan 30;16(3):584. doi: 10.3390/cancers16030584.